For most physicians, selling a medical practice is the largest financial transaction of their career and, often, the most complex. It’s not just a business decision. It’s the culmination of decades of training, care, and personal investment. Whether it’s the desire to retire or transition to a different role, the decision to sell can bring a mix of relief, uncertainty, and emotional weight.
This guide offers a physician-centered roadmap for preparing, evaluating, and executing a successful practice sale. It focuses on legal essentials, financial readiness, and strategies for maintaining continuity of care throughout the transition.
Whole person care is the future.
Fullscript puts it within reach.
healthcare is delivered.
Setting the Stage for a Successful Sale
Selling a medical practice involves more than a financial transaction—it’s a personal and professional turning point. To ensure a smooth process, it’s important to understand the motivations, define clear goals, and build a structured exit timeline.
Why Physicians May Sell Mid-Career
Many physicians are choosing to sell their practices well before retirement. The reasons are often layered:
- Professional transitions: Shifts to hospital employment or group practices are increasingly common, especially for those seeking administrative support or relief from the burdens of solo ownership.
- Emotional fatigue: Burnout, lifestyle changes, and pandemic-era exhaustion have led some physicians to seek new paths, such as part-time roles, teaching, or non-clinical positions.
- Market forces: Industry consolidation, payer complexity, and the rapid expansion of telehealth have changed the value and structure of independent practices.
Defining your goals before listing
Before listing a practice, physicians should identify their key priorities: financial, personal, and professional. These may include preparing for retirement, paying off debt, changing career direction, or preserving the legacy of patient care and staff employment.
Having clear goals helps shape negotiation strategy, buyer selection, and sale timing. It also aligns the sale with broader succession or estate plans
Building a strategic exit timeline
A structured exit timeline can reduce stress and prevent rushed decisions. Begin with a professional valuation 6 to 12 months ahead of the sale, allowing 3 to 6 months for negotiations and legal review, and at least 6 months for transition planning, including patient communication and onboarding of the new owner.
Additional steps include aligning the transaction with tax planning cycles, planning for real estate transfer 6 to 9 months before closing if property is owned, and starting EHR migration or custodianship agreements at least 90 days in advance.
Use project management tools like Asana or Trello to track tasks and deadlines. Early, organized preparation supports a smoother, more efficient sale.
Assembling the Right Advisory Team
A successful medical practice sale depends on more than a good buyer. Assembling a skilled and aligned advisory team is essential for navigating legal, financial, and operational complexities with confidence.
Core professionals you’ll need
Selling a practice requires a trusted advisory team to protect your interests and ensure compliance. Core members include a healthcare attorney for legal oversight, an accountant for tax and financial guidance, a consultant for operational analysis, a valuation expert, and potentially a mergers and acquisitions (M&A) broker to manage deal flow.
Additional support from a wealth advisor and tax strategist can help align sale proceeds with long-term financial and tax planning.
Avoiding conflicts of interest
While advisors are key partners, it’s important to ensure they are working in your best interest. Misaligned incentives can undermine your goals.
- Understand motivations: For example, brokers may prioritize closing a deal quickly to earn commissions, even if it’s not the best offer.
- Clarify roles and fees: Make sure each advisor’s scope of work and compensation is transparent. Confirm who serves in a fiduciary capacity, especially for financial and legal advisors.
Valuation and Goodwill
Determining a fair and defensible value for your medical practice is foundational to a successful sale. It influences buyer interest, impacts tax strategy, and ensures regulatory compliance.
What’s the practice worth?
A comprehensive practice valuation includes both physical and non-physical assets:
- Tangible assets: Medical equipment, technology, furniture, and any owned real estate.
- Intangible assets: Brand recognition, patient loyalty, staff expertise, and goodwill.
- Receivables: Outstanding accounts that will be collected post-sale.
Valuation professionals typically use one or more of the following methods:
- Income-based: Projects future cash flow and discounts it to present value.
- Asset-based: Total asset value minus liabilities, which is often used for practices nearing closure.
- Market-based: Compares the practice to similar recent sales, adjusted for specialty and geography.
Selecting the right method depends on the practice’s financial performance, specialty, and market dynamics.
Goodwill valuation
Goodwill is a major part of a practice’s value, reflecting intangible assets like reputation, location, payer mix, referrals, and operational strength. Common valuation methods include the weighted average profit method, which averages earnings over time, and the capitalization of excess earnings method, which values profit above a fair return on tangible assets.
Fair Market Value (FMV)
Documenting fair market value isn’t just good practice. It’s a regulatory requirement. Under laws like Stark and the Anti-Kickback Statute, practice sales must reflect FMV without regard to potential referral volume.
To meet this standard:
- Avoid informal or overly aggressive pricing that could imply future referral incentives.
- Engage independent third-party valuation experts to conduct and document the FMV assessment.
- Retain valuation reports and correspondence to support the sale structure in the event of an audit.
Choosing the Right Buyer and Sale Structure
The success of a practice sale depends not just on finding a buyer but on selecting the right buyer and structuring the deal in a way that aligns with your goals, protects legal interests, and ensures a smooth transition.
Common Buyer Types
Understanding the landscape of potential buyers helps physicians position their practice and evaluate fit:
- Independent physicians: May seek expansion or succession opportunities. Often prioritize continuity of care and staff retention.
- Larger medical groups or specialty aggregators: Typically offer integration benefits and administrative support but may bring changes to operations.
- Hospitals and health systems: Can offer financial security and infrastructure, but may involve longer negotiations and more bureaucracy.
- Private equity groups and multi-state operators (MSOs): These buyers often focus on scalability and profitability. They may offer significant capital but can shift practice culture and decision-making autonomy.
Each buyer type comes with trade-offs around autonomy, care models, and long-term financial implications.
Types of Sales
The deal structure significantly affects tax treatment, liability, and operational transition.
- Asset sale: The buyer purchases individual assets and assumes selected liabilities. This structure offers cleaner separation but can be more complex for regulatory compliance.
- Stock sale: The buyer purchases ownership interest, including all assets and liabilities. Simpler for transferring licenses and contracts, but carries more legal risk.
- Merger: Typically used for combining practices into a single entity. Can offer shared resources but requires deeper integration.
Each option has pros and cons depending on the seller’s priorities and the legal structure of the practice. Legal and tax advisors should guide the choice.
Regulatory Triggers
Healthcare transactions are closely regulated, and certain deal structures may trigger specific compliance requirements:
- Stark law and anti-kickback statute: Prohibit financial relationships tied to referrals unless structured under specific safe harbors. All compensation must reflect FMV.
- Fair market value (FMV): Must be clearly documented, particularly when selling to entities with potential referral relationships.
- State-level restrictions: Some states have corporate practice of medicine laws that limit who can own a medical practice. These are particularly relevant in hospital or MSO acquisitions.
Early legal review can help prevent regulatory issues from derailing a deal.
How to Vet a Prospective Buyer
Not all buyers are equal. Due diligence on the buyer is just as important as preparing your own practice:
- Warning signs: Lack of transparency, poor communication, limited operational history, or overly aggressive purchase terms.
- Financial review: Assess funding sources, cash flow stability, and recent acquisitions.
- Legal and compliance record: Look for any history of lawsuits, regulatory violations, or failed transactions.
- Cultural fit: Consider how their clinical philosophy and management style align with your own.
- References: Ask to speak with other physicians who have sold to the buyer to understand their experience.
Documentation and Due Diligence
Before any sale can move forward, both sides must engage in a thorough due diligence process. Preparing key documents in advance ensures transparency, accelerates negotiations, and demonstrates professionalism.
Prepare for buyer due diligence
Buyers will expect a full picture of the practice’s legal, financial, and operational standing. Commonly requested materials include:
- Corporate formation documents and operating agreements
- Three to five years of tax returns and financial statements
- Payer contracts and fee schedules
- Real estate leases or ownership records
- Employment agreements, compensation structures, and staff rosters
- Compliance logs, billing audits, and HIPAA risk assessments
- Patient volume data, referral trends, and appointment backlogs
Having these organized in a secure, digital format (like a virtual data room) can streamline buyer review and reduce deal friction.
Key pre-contract documents
Before executing a formal purchase agreement, two early-stage documents set the tone:
- Non-disclosure agreements (NDAs): Protect sensitive business and patient information during buyer evaluation.
- Letters of intent (LOIs): Outline key deal terms, including purchase structure (asset vs. stock), pricing framework, transition expectations, and exclusivity or standstill clauses.
Negotiating Key Deal Terms
Once documentation is in place and a buyer is selected, attention shifts to finalizing the terms of the deal. These negotiations determine not just the sale price, but also your future role, risk exposure, and tax outcomes.
Seller’s role post-sale
Clarify your responsibilities and compensation after the sale:
- Will you remain involved as a W-2 employee, independent contractor, or advisor?
- How long is the transition period, and are you expected to assist with patient retention or staff integration?
- Are there clinical expectations (like the number of shifts per week) or non-compete obligations?
The scope of your post-sale role can impact the valuation of goodwill and influence regulatory compliance.
Payment structures
Deal structure significantly affects financial and legal outcomes. Common payment models include:
- Lump sum: An immediate full payment at closing is simple but may trigger larger tax burdens.
- Installment payments: Spread over time to manage buyer liquidity, but may include interest.
- Earn-outs: Deferred payments based on post-sale performance metrics such as revenue or patient retention.
Emerging structures, especially with private equity buyers, may also include:
- Deferred compensation or equity rollovers, allowing sellers to retain financial interest in the new entity.
- Escrow accounts, clawback provisions, or performance milestones tied to patient retention or profitability.
If seller financing is offered, legal counsel should define interest rates, amortization terms, security agreements, and remedies for default. Always confirm whether the buyer has third-party financing or SBA loan pre-approval, which can affect deal certainty and timing.
Allocation and tax strategy
The way the purchase price is allocated has a direct impact on tax liability. Common allocation buckets include:
- Tangible assets: Subject to depreciation recapture.
- Goodwill: Typically taxed as capital gains.
- Non-compete agreements: May be taxed as ordinary income.
Work closely with a tax advisor to structure the sale in a way that minimizes double taxation and aligns with your long-term financial goals. Careful planning can significantly improve net proceeds after the sale.
Transition and Compliance Essentials
A well-managed transition helps preserve practice value, protects against legal risk, and ensures continuity of care. Even after the deal is signed, significant work remains to align systems, staff, and regulatory obligations.
Credentialing and payer enrollment
Once the practice changes ownership, providers must be re-credentialed under the new entity or the buyer’s payer contracts. Failure to do so can disrupt revenue flow and care delivery.
- Begin credentialing applications as early as possible to avoid delays.
- Coordinate with billing teams to track effective dates and prevent coverage gaps.
- Communicate proactively with patients and referral partners about any anticipated changes in insurance billing or coverage acceptance.
Credentialing timelines vary by payer, so build in flexibility and monitor closely.
Handling patient records
Transferring patient records must follow HIPAA and state retention rules. Notify patients of the ownership change and how to access their records. Set up custodianship agreements if needed. Plan early for electronic health record (EHR) compatibility to prevent data loss or disruption.
Employee transitions
Smooth staff transitions are key to maintaining morale and operational stability. Review employment contracts, identify who will stay on, and clarify new terms. Offer retention bonuses or phased transitions where appropriate.
Communicate openly to manage concerns, ensure WARN Act compliance if applicable, and handle benefit transfers like health coverage and retirement plans.
Legal disclosures and notifications
Ownership changes require formal notifications to the state medical board, DEA, and CMS, along with transferring or canceling licenses like CLIA or radiology permits. Confirm who handles post-sale medical record requests and secure malpractice tail coverage. Planning these tasks early with clear accountability reduces compliance risk and ensures a smooth transition.
Frequently Asked Questions (FAQs)
Selling a medical practice involves complex decisions, and many physicians have common concerns as they navigate the process. Below are answers to frequently asked questions to help guide planning and reduce uncertainty.
What’s the best way to calculate the fair market value of my practice?
Use a qualified third-party appraiser with healthcare experience who can apply income, asset, or market-based valuation methods, ensuring compliance and defensibility.
What are the tax consequences of an asset sale vs. a stock sale?
Asset sales often result in higher taxes due to depreciation recapture, while stock sales may qualify for capital gains treatment. Consult a tax advisor to model both scenarios.
How do I handle patient records legally during a sale?
Ensure HIPAA compliance, notify patients, and establish a custodianship or transfer plan. Follow federal and state-specific retention and access requirements.
Can I still work part-time in the practice after selling it?
Yes, but terms must be clearly defined in the sale agreement. Roles can range from employee to advisor, impacting compensation, compliance, and goodwill valuation.
What legal disclosures must I provide to potential buyers?
Disclose financials, payer contracts, leases, legal issues, and compliance documentation. Transparency helps reduce liability and supports a smoother negotiation.
How do I manage staff anxiety during a transition?
Communicate early and clearly. Share what’s known, provide timelines, and consider retention bonuses or phased transitions to support morale.
What red flags should I watch for when approached by a buyer or broker?
Be cautious of vague offers, rushed timelines, lack of financial transparency, or pressure to waive key due diligence. Always review terms with legal counsel.
Key Takeaways
- Selling a medical practice is a major financial and emotional milestone that requires physicians to clarify personal, professional, and financial goals before initiating the process.
- A successful sale depends on early planning, including a structured exit timeline, accurate valuation, and assembling a trusted team of legal, financial, and operational advisors.
- Understanding different buyer types (e.g., hospitals, private equity, solo physicians) and sale structures (asset, stock, or merger) is essential for aligning the deal with your long-term priorities and minimizing legal or tax risks.
- Ensuring fair market value, conducting buyer due diligence, and preparing key documents like NDAs and Letters of Intent help protect regulatory compliance and strengthen deal outcomes.
- Post-sale success hinges on smooth transitions in credentialing, patient records, staff management, and legal disclosures to maintain continuity of care and avoid disruptions
Disclaimer:
This article is for educational purposes only and does not constitute legal, financial, or medical advice. Physicians and healthcare professionals should consult qualified attorneys, financial advisors, and regulatory experts to ensure all aspects of a practice sale comply with applicable laws, contractual obligations, and professional standards. Decisions related to the sale or transition of a medical practice should be made based on individual circumstances and guided by appropriate professional counsel.
Whole person care is the future.
Fullscript puts it within reach.
healthcare is delivered.
References
- Anderson, S. G., Seay, M. C., Kim, K. T., & Lawson, D. R. (2023). Advisor compensation. Financial Services Review, 27(3), 231–255. https://doi.org/10.61190/fsr.v27i3.3396
- Barbopoulos, L. G., Paudyal, K., & Sudarsanam, S. (2017). Earnout deals: Method of initial payment and acquirers’ gains. European Financial Management, 24(5), 792–828. https://doi.org/10.1111/eufm.12135
- Bugeja, M., & Loyeung, A. (2015). What drives the allocation of the purchase price to goodwill? Journal of Contemporary Accounting & Economics, 11(3), 245–261. https://doi.org/10.1016/j.jcae.2015.10.002
- Casalino, L. P., Saiani, R., Bhidya, S., Khullar, D., & O’Donnell, E. (2019). Private Equity Acquisition of Physician Practices. Annals of Internal Medicine, 170(2), 114. https://doi.org/10.7326/m18-2363
- Cascardo, D. (2016). Pay Attention to Details when Selling Your Practice. The Journal of Medical Practice Management : MPM, 32(1), 13–15. https://pubmed.ncbi.nlm.nih.gov/30452837/
- Czinkota, M. R., Kotabe, M., Vrontis, D., & Shams, S. M. R. (2021). Understanding the Buyer. Springer Texts in Business and Economics, 135–176. https://doi.org/10.1007/978-3-030-66916-4_4
- Das, S. R., & Kim, S. (2017). Managing Rollover Risk with Capital Structure Covenants in Structured Finance Vehicles. The Journal of Fixed Income, 26(4), 92–112. https://doi.org/10.3905/jfi.2017.26.4.092
- Gordana Stojmenović, Tatjana Mrvić, Miodrag Smelcerović, & Pavle Trpeski. (2023). DETERMINING THE PURCHASE AND SALE VALUE OF SHARES BY ESTIMATING THE VALUE OF THE CAPITAL. SCIENCE International Journal, 2(3), 129–135. https://doi.org/10.35120/sciencej0203129s
- H. Vogel, MSN, FNP, AOCNP®, W. (2020). Determination of the Fair Market Value of Oncology Advanced Practitioners. Journal of the Advanced Practitioner in Oncology, 11(2). https://doi.org/10.6004/jadpro.2020.11.2.7
- Huang, S., Lien, J. W., Yang, S., & Zheng, J. (2024). Lump-sum tax or flat income tax? Welfare implications of taxation policy in the presence of social comparison. International Review of Economics & Finance. https://doi.org/10.1016/j.iref.2024.02.007
- Huttinger, R., & Aeddula, N. R. (2022). Stark Law. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559074/
- J.V. Fox, S. (2014). Incentives and limits in letters of intent: are they worth the paper they’re written on? International Journal of Law in the Built Environment, 6(3), 214–232. https://doi.org/10.1108/ijlbe-02-2013-0005
- Jacob, A. B. (2020). Mergers and Acquisitions: A Qualitative Study in the Medical Device Sector. International Journal of Management, Economics and Social Sciences, 9(3). https://doi.org/10.32327/ijmess/9.3.2020.9
- Johan, S. (2021). Merger and Acquisition Integration Model: A Practical Approach. JURNAL BISNIS STRATEGI, 30(1), 35–46. https://doi.org/10.14710/jbs.30.1.35-46
- Kurakova, O., & Orlov, A. (2019, January 1). Methodical and Practical Approaches to Goodwill Valuation. Www.atlantis-Press.com; Atlantis Press. https://doi.org/10.2991/iscfec-18.2019.85
- Lin, A. (2018). The Private Physician Practice’s Early Planning Considerations Under the New Tax Law. Missouri Medicine, 115(2), 112. https://pmc.ncbi.nlm.nih.gov/articles/PMC6139859/
- Maesen, S., & Ang, D. (2024). EXPRESS: Buy Now Pay Later: Impact of Installment Payments on Customer Purchases. Journal of Marketing, 89(3). https://doi.org/10.1177/00222429241282414
- Mavis, C. P., McNamee, N. P., Petmezas, D., & Travlos, N. G. (2020). Selling to buy: Asset sales and acquisitions. Journal of Corporate Finance, 62, 101587. https://doi.org/10.1016/j.jcorpfin.2020.101587
- McNary, A. L. (2021). Maintenance and Destruction of Treatment Records. Innovations in Clinical Neuroscience, 18(4-6), 44. https://pmc.ncbi.nlm.nih.gov/articles/PMC8667710/
- Mohd Rohaizad, N. F. H., Hamzah, E., Abdullah Hashim, H., & Ismail, A. (2021). TANGIBLE AND INTANGIBLE FACTORS INCORPORATED FOR INFRASTRUCTURE ASSET VALUATION. PLANNING MALAYSIA, 19(17). https://doi.org/10.21837/pm.v19i17.982
- O’Connell, R., Hosain, F., Colucci, L., Nath, B., & Melnick, E. R. (2023). Why Do Physicians Depart Their Practice? A Qualitative Study of Attrition in a Multispecialty Ambulatory Practice Network. Journal of the American Board of Family Medicine, 36(6), 1050–1057. https://doi.org/10.3122/jabfm.2023.230052r2
- Onuchic, P. (2025). Advisors with Hidden Motives. https://doi.org/10.2139/ssrn.5186490
- Patel, R., & Sharma, S. (2022, October 24). Credentialing. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK519504/
- Shanafelt, T. D., Hasan, O., Dyrbye, L. N., Sinsky, C., Satele, D., Sloan, J., & West, C. P. (2015). Changes in Burnout and Satisfaction With Work-Life Balance in Physicians and the General US Working Population Between 2011 and 2014. Mayo Clinic Proceedings, 90(12), 1600–1613. https://doi.org/10.1016/j.mayocp.2015.08.023
- Sibalija, J., Barrett, D., Subasri, M., Bitacola, L., & Kim, R. B. (2021). Understanding value in a healthcare setting: An application of the business model canvas. Methodological Innovations, 14(3), 205979912110504. Sagepub. https://doi.org/10.1177/20597991211050477
- Silver, M. P., Hamilton, A. D., Biswas, A., & Warrick, N. I. (2016). A systematic review of physician retirement planning. Human Resources for Health, 14(1). https://doi.org/10.1186/s12960-016-0166-z
- Srivastava, R. K. (2018). Managing mergers and acquisitions in health care: A case study in the pharmaceutical sector. International Journal of Healthcare Management, 1–13. https://doi.org/10.1080/20479700.2017.1422337
- Subbiah, P., & Scheffler, R. M. (2025). When Does Private Equity Ownership of Physician Practices Violate “First, Do No Harm”?. AMA Journal of Ethics, 27(5), 376–381. https://doi.org/10.1001/amajethics.2025.376.
- Tariq, R. A., & Hackert, P. B. (2023). Patient confidentiality. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK519540/
- Xu, L., & Naunheim, M. R. (2025). What Are Physicians’ Duties to Patients When They Sell Their Practices? The AMA Journal of Ethic, 27(5), E308-317. https://doi.org/10.1001/amajethics.2025.308
- Zhu, J. M., Rooke-Ley, H., & Erin Fuse Brown. (2023). A Doctrine in Name Only — Strengthening Prohibitions against the Corporate Practice of Medicine. The New England Journal of Medicine, 389(11), 965–968. https://doi.org/10.1056/nejmp2306904